未登录

P

Patricia G. Yancey

Vanderbilt University

H指数:41

被引数:6,866

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy

CIRCULATION RESEARCH

IF16.2

2023-05-2626

OA

Statin Dose Is Associated With Improved HDL Anti-inflammatory Capacity In Cardiac And Vascular Surgery Patients; Possible Mechanism For Statin Mediated Enhancement Of The Association Between Higher HDL And Less Kidney Injury After Surgery

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2023-05-010

PRE

Scavenging dicarbonyls with 5'-O-pentyl-pyridoxamine increases HDL net cholesterol efflux capacity and attenuates atherosclerosis and insulin resistance

MOLECULAR METABOLISM

IF6.6

2023-01-018

OAAI

High Density Lipoprotein Cholesterol Efflux Capacity And Delirium After Surgery

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2022-05-010

PRE

The FoxOs are in the ApoM house

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2022-04-010

OAAI

Kidney injury-mediated disruption of intestinal lymphatics involves dicarbonyl-modified lipoproteins

KIDNEY INTERNATIONAL

IF12.6

2021-09-0114

OAAI

Macrophage SR-BI modulates autophagy via VPS34 complex and PPARα transcription of Tfeb in atherosclerosis

巨噬细胞sr-bi通过VPS34复合物和Tfeb的ppar α 转录调节自噬在动脉粥样硬化中的作用

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2021-04-0155

OA

Perioperative high density lipoproteins, oxidative stress, and kidney injury after cardiac surgery

JOURNAL OF LIPID RESEARCH

IF4.1

2021-01-016

OAAI

Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr-/- mice

NATURE COMMUNICATIONS

IF15.7

2020-08-1446

OAAI

Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity

IF5

2020-06-3012

OAAI

Modified sites and functional consequences of 4-oxo-2-nonenal adducts in HDL that are elevated in familial hypercholesterolemia

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2019-12-0115

OAAI

Lipoprotein modulation of proteinuric renal injury

LABORATORY INVESTIGATION

IF4.2

2019-08-0111

OAAI

IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF7.1

2019-04-2323

OAAI

Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation

CIRCULATION RESEARCH

IF16.2

2019-02-1543

OAAI

Administration of N-Acyl-Phosphatidylethanolamine Expressing Bacteria to Low Density Lipoprotein Receptor-/- Mice Improves Indices of Cardiometabolic Disease

SCIENTIFIC REPORTS

IF3.9

2019-01-2326

OAAI

Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2018-06-0140

OAAI

Investigation of 4-oxo-2-nonenal Mediated HDL Dysfunction and the Use of Lipid Dicarbonyl Scavengers in Preserving HDL Function

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2018-05-010

PRE

Scavenging Reactive Aldehydes With 5′-o-pentyl-pyridoxamine (PPM) Improves HDL Function and Reduces Atherosclerosis in Ldlr Deficient Mice

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2018-05-010

PRE

SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis

TRENDS IN ENDOCRINOLOGY AND METABOLISM

IF12.6

2017-06-01165

OAAI

Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis

ARTHRITIS & RHEUMATOLOGY

IF10.9

2016-08-2532

OA